Featured Research

from universities, journals, and other organizations

Powerful bacterial immune response defined by new study

Date:
February 6, 2014
Source:
University of California - Davis
Summary:
A previously undefined T-cell immune response to rapid infections by bacteria like Salmonella and Chlamydia is described in a new article, helping pave the way for development of vaccines and therapeutics.

T-cells, the elite guard of the immune system in humans and other mammals, ignore normal biologic protocol and swing into high gear when attacked by certain fast-moving bacteria, reports a team of researchers led by a UC Davis immunologist.

The description of this previously undefined immune pathway provides information vital for designing vaccines and medicines to prevent or treat deadly infectious diseases caused by bacteria such as Salmonella and Chlamydia. The results from this recent mouse-based study will be reported online Feb. 6 in the journal Immunity.

"Our study shows that the body's immune system functions very differently when it faces a rapidly growing pathogen like Salmonella or Chlamydia," said immunologist Stephen McSorley, an associate professor at UC Davis' Center for Comparative Medicine, which investigates diseases that afflict both humans and animals.

"The strict rules that normally govern T-cell activation are relaxed so that the host animal has the best possible chance of a maximal response and ultimately staying alive," he said.

T-cells, which belong to a group of white blood cells called lymphocytes, normally respond defensively to the presence of substances known as antigens, which are produced by invading bacteria and viruses. It's widely known that T-cells launch an immune defense when they recognize specific antigens.

However in this study, the researchers demonstrated in the mouse that certain T-cells don't require the presence of specific antigens to launch an effective immune response. During fast-moving Salmonella and Chlamydia infections, a cascade of other antimicrobial interactions occur that trigger these T-cells to respond defensively to the bacterial attacks, even without the presence of specific antigens.

The researchers also showed that when this defensive pathway was disrupted during Salmonella infection, the mice had greater difficulty getting rid of the bacterial disease.

The researchers note that further study is needed to determine if this newly defined antimicrobial pathway also can provide protection against co-infections by multiple disease-causing microbes.


Story Source:

The above story is based on materials provided by University of California - Davis. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hope O’Donnell, OanhH. Pham, Lin-xi Li, ShaikhM. Atif, Seung-Joo Lee, MariettaM. Ravesloot, JessicaL. Stolfi, Sean-Paul Nuccio, Petr Broz, DeniseM. Monack, AndreasJ. Baumler, StephenJ. McSorley. Toll-like Receptor and Inflammasome Signals Converge to Amplify the Innate Bactericidal Capacity of T Helper 1 Cells. Immunity, 2014; DOI: 10.1016/j.immuni.2013.12.013

Cite This Page:

University of California - Davis. "Powerful bacterial immune response defined by new study." ScienceDaily. ScienceDaily, 6 February 2014. <www.sciencedaily.com/releases/2014/02/140206133642.htm>.
University of California - Davis. (2014, February 6). Powerful bacterial immune response defined by new study. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/02/140206133642.htm
University of California - Davis. "Powerful bacterial immune response defined by new study." ScienceDaily. www.sciencedaily.com/releases/2014/02/140206133642.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins